Cholera vaccine
Ehara, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 5): 625-630
2005
ISSN/ISBN: 0047-1852 PMID: 15954420 Document Number: 586351
Document emailed within 1 workday
Related Documents
Ali, M.; Emch, M.; Yunus, M.; Sack, D.; Lopez, A.L.; Holmgren, J.; Clemens, J. 2008: Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission Pediatric Infectious Disease Journal 27(1): 33-37Pal, S.C.; Deb, B.C. 1989: The present status of cholera vaccine Journal of the Indian Medical Association 87(5): 105-106
Holmgren, J.; Svennerholm, A.M. 1989: An effective peroral cholera vaccine developed in Sweden Lakartidningen 86(8): 629-631
Svennerholm, A.M.; Jertborn, M.; Gothefors, L.; Karim, A.; Sack, D.A.; Holmgren, J. 1983: Current status of an oral B subunit whole cell cholera vaccine Developments in Biological Standardization 53: 73-79
Chaicumpa, W.; Chaisri, U.; Tapchaisri, P.; Chongsa-Nguan, M.; Pongponratn, E. 1987: Oral vaccine against cholera prepared from Vibrio cholerae antigen(s) Southeast Asian Journal of Tropical Medicine and Public Health 18(2): 142-148
Dingeldein, W.; Becker, W.; Manz, D.; Tiefenbach, B.; Wachendorfer, G. 1976: Use of the live hog cholera vaccine Suiferin C in breeding stock. 1. Effects on reproduction Deutsche Tierärztliche Wochenschrift 83(4): 129-133
Dzhaparidze, M.N.; Nikitina, G.P.; Kulikova, V.L.; Popov, A.A.; Naumov, A.V. 1984: Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 70-74
Chirescu, N.; Popescu, G.; Popovici, M. 1970: Seroprotection of chick embryo used as indicator test for the effectiveness of cholera vaccine Archives Roumaines de Pathologie Experimentales et de Microbiologie 29(3): 545-547
Dimitrov, K.; Gavrilov, N. 1975: Antibody formation in swine vaccinated with a lapinized K-vaccine and serum against hog cholera Veterinarno-Meditsinski Nauki 12(9): 40-45
Holmgren, J.; Svennerholm, A.M.; Clemens, J.; Sack, D.; Black, R.; Levine, M. 1987: An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial Advances in Experimental Medicine and Biology 216b: 1649-1660
Sumarokov, A.A.; Dzhaperidze, M.N.; Ivanov, N.R.; Karaeva, L.T.; Popov, A.A. 1977: Standardization of chemical cholerogen-toxoid cholera vaccine according to the content of somatic O-antigen Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1977(4): 99-106
Glass, R.I.; Svennerholm, A.M.; Stoll, B.J.; Khan, M.R.; Huda, S.; Huq, M.I.; Holmgren, J. 1989: Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine Pediatric Infectious Disease Journal 8(2): 105-109
2014: Oral cholera vaccine campaign among internally displaced persons in South Sudan Releve Epidemiologique Hebdomadaire 89(20): 214-220
Dzhaparidze, M.N.; Naumov, A.V.; Nikitina, G.P.; Meleshchenko, M.V.; Dobrova, G.V.; Zavorotnykh, V.I.; Gracheva, V.P.; Zakharova, T.L. 1991: An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 31-33
Wiedermann, U.; Hanson, L.A.; Holmgren, J.; Dahlgren, U.I. 1995: Impaired mucosal immune response in vitamin a deficient rats immunized with oral cholera vaccine Advances in Experimental Medicine and Biology 371b: 1629-1631
Khatib, A.M.; Ali, M.; von Seidlein, L.; Kim, D.R.; Hashim, R.; Reyburn, R.; Ley, B.; Thriemer, K.; Enwere, G.; Hutubessy, R.; Aguado, M.T.; Kieny, M.-P.; Lopez, A.L.; Wierzba, T.F.; Ali, S.M.; Saleh, A.A.; Mukhopadhyay, A.K.; Clemens, J.; Jiddawi, M.S.; Deen, J. 2012: Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study LANCET. Infectious Diseases 12(11): 837-844
Perry, R.T.; Plowe, C.V.; Koumaré, B.; Bougoudogo, F.; Kotloff, K.L.; Losonsky, G.A.; Wasserman, S.S.; Levine, M.M. 1998: A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali Bulletin of the World Health Organization 76(1): 63-71
Kar, S.K.; Sah, B.; Patnaik, B.; Kim, Y.H.; Kerketta, A.S.; Shin, S.; Rath, S.B.; Ali, M.; Mogasale, V.; Khuntia, H.K.; Bhattachan, A.; You, Y.A.; Puri, M.K.; Lopez, A.L.; Maskery, B.; Nair, G.B.; Clemens, J.D.; Wierzba, T.F. 2014: Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model Plos Neglected Tropical Diseases 8(2): E2629
Ahmed, T.; Svennerholm, A-Mari.; Al Tarique, A.; Sultana, G.N.N.; Qadri, F. 2009: Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding Vaccine 27(9): 1433-1439
Semá Baltazar, C.; Rafael, F.; Langa, Jé.Paulo.M.; Chicumbe, S.; Cavailler, P.; Gessner, B.D.; Pezzoli, L.; Barata, Aérico.; Zaina, D.; Inguane, Déia.L.; Mengel, M.A.; Munier, A. 2018: Oral cholera vaccine coverage during a preventive door-to-door mass vaccination campaign in Nampula, Mozambique Plos one 13(10): E0198592